Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Change in Inventory (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Change in Inventory readings, the most recent being -$244000.0 for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 448.57% to -$244000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $308000.0, a 156.0% increase, with the full-year FY2025 number at $308000.0, up 156.0% from a year prior.
  • Change in Inventory hit -$244000.0 in Q4 2025 for Arcadia Biosciences, down from -$33000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.0 million in Q3 2021 to a low of -$669000.0 in Q1 2022.
  • Median Change in Inventory over the past 5 years was -$40000.0 (2022), compared with a mean of $172100.0.
  • Biggest five-year swings in Change in Inventory: soared 2293.62% in 2023 and later crashed 918.92% in 2024.
  • Arcadia Biosciences' Change in Inventory stood at -$268000.0 in 2021, then skyrocketed by 82.46% to -$47000.0 in 2022, then soared by 2293.62% to $1.0 million in 2023, then tumbled by 93.21% to $70000.0 in 2024, then tumbled by 448.57% to -$244000.0 in 2025.
  • The last three reported values for Change in Inventory were -$244000.0 (Q4 2025), -$33000.0 (Q3 2025), and $204000.0 (Q2 2025) per Business Quant data.